Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.54 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.54 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.54 |
| ▸ | NAMPT | P43490 | 6/20 | 0.50 |
| ▸ | GPR183 | P32249 | 1/20 | 0.50 |
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.47 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.42 |
| ▸ | HSD17B3 | P37058 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30575059 | 0.81 | DPP8 (0.56) | DPP8DPP9DPP7NAMPTABHD6 | |
| SCHEMBL30297512 | 0.80 | ABHD6 (0.52) | DPP8DPP9DPP7NAMPTABHD6 | |
| SCHEMBL20617796 | 0.79 | DPP8 (0.51) | DPP8DPP9DPP7NAMPTABHD6 | |
| SCHEMBL20424518 | 0.79 | DPP8 (0.51) | DPP8DPP9DPP7NAMPTABHD6 | |
| SCHEMBL30575108 | 0.78 | DPP8 (0.50) | DPP8DPP9DPP7NAMPTABHD6 | |
| SCHEMBL16101941 | 0.77 | NOTUM (0.60) | DPP8DPP9DPP7NAMPTABHD6 | |
| SCHEMBL6231359 | 0.77 | DPP8 (0.52) | DPP8DPP9DPP7NAMPTABHD6 | |
| SCHEMBL31432865 | 0.76 | DPP7 (0.69) | DPP8DPP9DPP7NAMPTABHD6 | |
| SCHEMBL17560188 | 0.76 | NAMPT (0.58) | DPP8DPP9DPP7NAMPTABHD6 | |
| SCHEMBL31463256 | 0.75 | DPP7 (0.57) | DPP8DPP9DPP7NAMPTABHD6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025088073-A1 | HETEROCYCLIC COMPOUNDS AS BLT2 AGONISTS AND THEIR MEDICAL USE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-05-01 | — | — | WO | disclosed |
| EP-4545138-A1 | HETEROCYCLIC COMPOUNDS AS BLT2 AGONISTS AND THEIR MEDICAL USE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-04-30 | — | — | EP | disclosed |